Skip to main content
Top
Published in: Acta Diabetologica 4/2008

01-12-2008 | Original Article

Sleep abnormalities in type 2 diabetes may be associated with glycemic control

Authors: M. Trento, F. Broglio, F. Riganti, M. Basile, E. Borgo, C. Kucich, P. Passera, P. Tibaldi, M. Tomelini, F. Cavallo, E. Ghigo, M. Porta

Published in: Acta Diabetologica | Issue 4/2008

Login to get access

Abstract

Sleep disturbances may be associated with impaired glucose metabolism. The aim of this study was to evaluate sleep duration and quality in relation to glycemic control in patients with type 2 diabetes. In a cross-sectional study, sleep duration and quality were assessed in 47 middle-aged patients with type 2 diabetes treated with oral agents and without sleep disturbing complications and 23 healthy control subjects similar by age, sex, body mass index, occupation and schooling. Sleep was recorded by wrist-actigraphy for three consecutive days under free-living conditions. Univariate analysis showed lower sleep maintenance (P = 0.002) and sleep efficiency (P = 0.005), and higher fragmentation index (P < 0.0001), total activity score (P = 0.05) and moving time (P < 0.0001) in patients with type 2 diabetes. After adjusting for age, gender and schooling, fragmentation index and moving time remained significantly higher in the patients with diabetes (P < 0.05, both). HbA1c correlated inversely with sleep efficiency (r = −0.29; P = 0.047) and positively with moving time (r = 0.31; P = 0.031). These findings suggest that type 2 diabetes is associated with sleep disruptions even in the absence of complications or obesity. The relevance of sleep abnormalities to metabolic control and possible strategies to improve sleep quality in type 2 diabetes deserve further investigation.
Literature
1.
go back to reference Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP (2001) The continuing epidemics of obesity and diabetes in the United States. JAMA 286:1195–1200PubMedCrossRef Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP (2001) The continuing epidemics of obesity and diabetes in the United States. JAMA 286:1195–1200PubMedCrossRef
2.
go back to reference McKinlay J, Marceau L (2000) US public health and the 21st century: diabetes mellitus. Lancet 356:757–761PubMedCrossRef McKinlay J, Marceau L (2000) US public health and the 21st century: diabetes mellitus. Lancet 356:757–761PubMedCrossRef
3.
go back to reference Webb WB, Agnew HW (1975) Are we chronically sleep deprived? Bull Psychon Soc 6:47 Webb WB, Agnew HW (1975) Are we chronically sleep deprived? Bull Psychon Soc 6:47
4.
go back to reference National Sleep Foundation (2003) Sleep in America poll 2003. National Sleep Foundation, Washington DC National Sleep Foundation (2003) Sleep in America poll 2003. National Sleep Foundation, Washington DC
5.
go back to reference Bonnet MH, Arand DL (1995) We are chronically sleep deprived. Sleep 18:908–911PubMed Bonnet MH, Arand DL (1995) We are chronically sleep deprived. Sleep 18:908–911PubMed
6.
go back to reference Chokroverty S (1999) Sleep disorders medicine: basic science, technical considerations, and clinical aspects, 2nd ed., Butterworth and Heinemann Boston, pp 14–16 Chokroverty S (1999) Sleep disorders medicine: basic science, technical considerations, and clinical aspects, 2nd ed., Butterworth and Heinemann Boston, pp 14–16
7.
go back to reference Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR (2002) Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 59:131–136PubMedCrossRef Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR (2002) Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 59:131–136PubMedCrossRef
8.
go back to reference Kojima M, Wakai K, Kawamura T, Tamakoshi A, Aoki R, Lin Y, Nakayama T, Horibe H, Aoki N, Ohno Y (2000) Sleep patterns and total mortality: a 12-year follow-up study in Japan. J Epidemiol 10:87–93PubMed Kojima M, Wakai K, Kawamura T, Tamakoshi A, Aoki R, Lin Y, Nakayama T, Horibe H, Aoki N, Ohno Y (2000) Sleep patterns and total mortality: a 12-year follow-up study in Japan. J Epidemiol 10:87–93PubMed
9.
go back to reference Nilsson PM, Nilsson JA, Hedblad B, Berglund G (2001) Sleep disturbance is associated with elevated pulse rate for prediction of mortality: consequences of mental strain? J Intern Med 250:521–529PubMedCrossRef Nilsson PM, Nilsson JA, Hedblad B, Berglund G (2001) Sleep disturbance is associated with elevated pulse rate for prediction of mortality: consequences of mental strain? J Intern Med 250:521–529PubMedCrossRef
10.
go back to reference Mallon L, Broman J-E, Hetta J (2002) Sleep complaints predict coronary artery disease mortality in males: a 12-year follow-up study of a middle-aged Swedish population. J Intern Med 251:207–216PubMedCrossRef Mallon L, Broman J-E, Hetta J (2002) Sleep complaints predict coronary artery disease mortality in males: a 12-year follow-up study of a middle-aged Swedish population. J Intern Med 251:207–216PubMedCrossRef
11.
go back to reference Ayas NT, White DP, Manson JE et al (2003) A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med 163:205–209PubMedCrossRef Ayas NT, White DP, Manson JE et al (2003) A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med 163:205–209PubMedCrossRef
12.
go back to reference Spiegel K, Leproult R, Van Cauter E (1999) Impact of sleep debt on metabolic and endocrine function. Lancet 354:1435–1439PubMedCrossRef Spiegel K, Leproult R, Van Cauter E (1999) Impact of sleep debt on metabolic and endocrine function. Lancet 354:1435–1439PubMedCrossRef
13.
go back to reference Spiegel K, Knutson K, Leproult R, Tasai E, Van Cauter E (2005) Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol 99:2008–2019PubMedCrossRef Spiegel K, Knutson K, Leproult R, Tasai E, Van Cauter E (2005) Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol 99:2008–2019PubMedCrossRef
14.
go back to reference Vgontzas AN, Mastorakos G, Bixler EO, Kales A, Gold PW, Chrousos GP (1999) Sleep deprivation effects on the activity of the hypothalamic-pituitary-adrenal and growth axes: potential clinical implications. Clin Endocrinol 51:205–215CrossRef Vgontzas AN, Mastorakos G, Bixler EO, Kales A, Gold PW, Chrousos GP (1999) Sleep deprivation effects on the activity of the hypothalamic-pituitary-adrenal and growth axes: potential clinical implications. Clin Endocrinol 51:205–215CrossRef
15.
go back to reference Lamond N, Tiggemann M, Dawson D (2000) Factors predicting sleep disruption in Type 2 diabetes. Sleep 23:415–416PubMed Lamond N, Tiggemann M, Dawson D (2000) Factors predicting sleep disruption in Type 2 diabetes. Sleep 23:415–416PubMed
16.
go back to reference Knutson KL, Ryden AM, Mander BA, Van Cauter E (2006) Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus. Arch Intern Med 166:1768–1774PubMedCrossRef Knutson KL, Ryden AM, Mander BA, Van Cauter E (2006) Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus. Arch Intern Med 166:1768–1774PubMedCrossRef
17.
go back to reference Yaggi HK, Araujo AB, McKinlay JB (2006) Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care 29:657–661PubMedCrossRef Yaggi HK, Araujo AB, McKinlay JB (2006) Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care 29:657–661PubMedCrossRef
18.
go back to reference Perciaccante A, Fiorentini A, Paris A, Serra P, Tubani L (2006) Circadian rhythm of the autonomic nervous system in insulin resistant subjects with normoglycemia, impaired fasting glycemia, impaired glucose tolerance, type 2 diabetes mellitus. BMC Cardiovasc Disord 6:1–10CrossRef Perciaccante A, Fiorentini A, Paris A, Serra P, Tubani L (2006) Circadian rhythm of the autonomic nervous system in insulin resistant subjects with normoglycemia, impaired fasting glycemia, impaired glucose tolerance, type 2 diabetes mellitus. BMC Cardiovasc Disord 6:1–10CrossRef
19.
go back to reference Akley NR (1997) Validation with polysomnography of the sleepwatch sleep/wake scoring algorithm used by the actiwatch activity monitoring system. Technical Report to Mini Mitter Co, Inc Akley NR (1997) Validation with polysomnography of the sleepwatch sleep/wake scoring algorithm used by the actiwatch activity monitoring system. Technical Report to Mini Mitter Co, Inc
20.
go back to reference American Sleep Disorders Association, An American Sleep Disorders Association Report (1995) Practice parameters for the use of actigraphy in the clinical assessment of sleep disorders. Sleep 18:285–287 American Sleep Disorders Association, An American Sleep Disorders Association Report (1995) Practice parameters for the use of actigraphy in the clinical assessment of sleep disorders. Sleep 18:285–287
21.
go back to reference Rechtschaffen A, Bergmann BM, Everson CA, Kushida CA, Gilliland MA (2002) Sleep deprivation in the rat: X integration and discussion of the findings. Sleep 25:68–87PubMed Rechtschaffen A, Bergmann BM, Everson CA, Kushida CA, Gilliland MA (2002) Sleep deprivation in the rat: X integration and discussion of the findings. Sleep 25:68–87PubMed
22.
go back to reference Van Cauter E, Holmback U, Knutson K, Leproult R, Miller A, Nedeltcheva A, Pannain S, Penev P, Tasali E, Spiegel K (2007) Impact of sleep and sleep loss on neuroendocrine and metabolic function. Horm Res 67(Suppl 1):2–9PubMedCrossRef Van Cauter E, Holmback U, Knutson K, Leproult R, Miller A, Nedeltcheva A, Pannain S, Penev P, Tasali E, Spiegel K (2007) Impact of sleep and sleep loss on neuroendocrine and metabolic function. Horm Res 67(Suppl 1):2–9PubMedCrossRef
23.
go back to reference Knutson KL, Spiegel K, Penev P, Van Cauter E (2007) The metabolic consequences of sleep deprivation. Sleep Med Rev 11:163–178PubMedCrossRef Knutson KL, Spiegel K, Penev P, Van Cauter E (2007) The metabolic consequences of sleep deprivation. Sleep Med Rev 11:163–178PubMedCrossRef
24.
go back to reference Resnick HE, Redline S, Shahar E, Gilpin A, Newman A, Wlater R, Ewy GA, Howard BV, Punjabi NM (2003) Diabetes and sleep disturbances: findings from the sleep Heart Study. Diabetes Care 26:702–709PubMedCrossRef Resnick HE, Redline S, Shahar E, Gilpin A, Newman A, Wlater R, Ewy GA, Howard BV, Punjabi NM (2003) Diabetes and sleep disturbances: findings from the sleep Heart Study. Diabetes Care 26:702–709PubMedCrossRef
25.
go back to reference Wandel PE, Brosson B, Aberg H (1999) Quality of life in relation to comorbidity among diabetic patients followed for three years in Swedish primary health care. Diabetes Metab 25:424 Wandel PE, Brosson B, Aberg H (1999) Quality of life in relation to comorbidity among diabetic patients followed for three years in Swedish primary health care. Diabetes Metab 25:424
Metadata
Title
Sleep abnormalities in type 2 diabetes may be associated with glycemic control
Authors
M. Trento
F. Broglio
F. Riganti
M. Basile
E. Borgo
C. Kucich
P. Passera
P. Tibaldi
M. Tomelini
F. Cavallo
E. Ghigo
M. Porta
Publication date
01-12-2008
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 4/2008
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-008-0047-6

Other articles of this Issue 4/2008

Acta Diabetologica 4/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine